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ABSTRACT
Protein disulfide isomerase (PDI) is crucial in the redox of disulfide bonds, where
it catalyzes reductase, oxidase, and isomerase activity. The active site motif for PDI is
CXXC, which is found in the a and a’ domain. PDI is mainly localized to the
endoplasmic reticulum, where it plays a key role in the folding of new proteins through
proper disulfide formation.
With new studies about the regulation of protein activity by lysine acetylation,
our group wished investigate this post-translational modification on PDI. Flanking each
active site motif of PDI is a lysine residue. These active site-flanking lysine residues were
mutated individually and together to observe if any catalytic change occurred. Mutation
of the lysine residue to glutamine, alanine, or glutamic acid resulted in a decrease in
activity, indicating the importance of the lysine residue for optimal PDI activity.
Acetylation of PDI was performed by acetic anhydride, where through mass
spectrometry, PDI was observed to be partially acetylated. The catalytic efficiency of the
acetylated wt-PDI was observed to decrease in comparison to un-acetylated PDI.
Indicating that acetylation of PDI may be a possible regulator of PDI redox activity.
[Master’s Thesis or Major Paper 150 words max]
[PhD Dissertation 350 words max]
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1! Introduction
1.1! Protein folding and the importance of disulfide bonds
The unique functions carried out by proteins come in part due to their threedimensional (3D) structure (Dill & MacCallum, 2012). Much scientific research has and
still is being performed to understand how a one-dimensional chain of amino acids can
quickly fold into the native protein structure (Dill & MacCallum, 2012). One of the
hypotheses that try to explain the ability of an amino acid chain to quickly fold into the
native state without stopping at any of the multiple stable conformations is the folding
funnel hypothesis. This hypothesis states that the native structure of the protein has such
a low free energy that it becomes unlikely that the protein will stay in a non-native stable
conformation for long (Onuchic & Wolynes, 2004).
Predicting the mechanism of protein folding becomes more complex when
considering the formation of a disulfide bonds within a protein (Narayan, 2012). A
disulfide bond is a covalent bond between the thiol groups of two cysteines and plays an
important role in protein folding and the stability of the native structure (Mamathambika
& Bardwell, 2008). Disulfide bonds have also been shown to play functional roles at
either the active site of proteins or at allosteric sites where they regulate enzyme activity
(Mamathambika & Bardwell, 2008). Some of the major factors that affect disulfide bond
formation are the concentration of thiolates, the accessibility of the thiols, the proximity
of the thiols, and the reactivity of the thiols based on the microenvironment
(Mamathambika & Bardwell, 2008). Incorrect disulfide bond formation can cause
improper protein folding leading to protein aggregation followed by degradation
(Mamathambika & Bardwell, 2008). This is the reason that proteins such as protein
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disulfide isomerase are so important; they help with the formation, reduction, and/or
isomerization of disulfide bonds (Mamathambika & Bardwell, 2008).
1.2! Protein disulfide isomerase (PDI)
1.2.1! Overview
The first reported observable activity of protein disulfide isomerase (PDI: EC
5.3.4.1) occurred in 1963 by Anfinsen’s group. They observed the re-oxidation of RNase
by rat liver microsomes fraction and from soluble nonprotein factors (Goldberger,
Epstein, & Anfinsen, 1963). By 1964, Anfinsen’s group was able to further purify the
microsomes fraction to just a protein sample, where they correctly hypothesized that this
protein may be able to facilitate the conversion of disulfide bonds on multiple proteins
(Goldberger, Epstein, & Anfinsen, 1964). PDI was observed to reduce and isomerize
disulfide bonds as well as oxidize thiols (Figure 1)(Holmgren, 1968). The active site
sequence of rat PDI was later determined to be WCGHCK a similar sequence found in
the thioredoxin family (Edman, Ellis, Blacher, Roth, & Rutter, 1985). It was later
determined that PDI contains four thioredoxin-like domains and is now categorized as
being a part of the thioredoxin superfamily (Alanen et al., 2003; Freedman et al., 1998).
PDI is also the model protein for the PDI family, which contains 20 different isoforms
(Kozlov, Maattanen, Thomas, & Gehring, 2010).
In 1994, it was discovered that PDI possess chaperone activity in addition to the
aforementioned thiol redox activity (Cai, Wang, & Tsou, 1994). It was later determined
that this chaperone activity worked independently of the redox status of active site

2

Figure 1. The 3 main redox reaction catalyzed by PDI: oxidation of thiols, reduction of
disulfide, and isomerization of disulfide.
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thiols (McLaughlin & Bulleid, 1998). The three catalytic activities of PDI, thiol redox,
disulﬁde exchange, and chaperone are central to endoplasmic reticulum (ER) function,
where PDI is highly expressed (Maattanen, Gehring, Bergeron, & Thomas, 2010).
Although PDI has a C-terminal KDEL ER retention sequence, significant amounts of this
protein were shown to escape the ER and were detected in the nucleus, cytosol, cell
surface, and extracellularly (Edman et al., 1985; Koch, 1987; Yoshimori et al., 1990). It
is important to state that PDI is expressed in almost all mammalian tissues, playing
important role in redox and chaperone activity (Marcus, Shaffer, Farrar, & Green, 1996;
Noiva, 1999).
1.2.2! Structural importance of PDI and the interplay with catalytic activity
All members of the PDI family contain at least one thioredoxin-like domain
structure characterized as a βαβαβαββα fold (Kemmink, Darby, Dijkstra, Nilges, &
Creighton, 1997). PDI is comprised of 5 domains abb’a’c where abb’a’ are thioredoxinlike domains and c is an acidic domain (Figure 2)(Freedman et al., 1998; Koivunen et al.,
1999). In the c domain there is an ER retention sequence KDEL at the C-terminal
(Edman et al., 1985). The a and a’ domains contain the thiol redox catalytic motif
CXXC, whereas the b and b’ domains do not contain this motif (Freedman et al., 1998).
There is a small chain of amino acids between the b’ and a’ domains known as the xlinker, which is believed to provide some flexibility to the protein (C. Wang et al., 2013).
The N-terminal cysteine in the catalytic motif (CXXC) is observed to have a pKa of 4.8
whereas the C-terminal cysteine (CXXC) pKa is reported to be 10 (Karala, Lappi, &
Ruddock, 2010; Nelson & Creighton, 1994). The low pKa of the N-terminal cysteine will
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Figure 2. Crystal Structure of Reduced and Oxidized PDI. (A) Reduced crystal structure
of human PDI (PDB ID: 4EKZ). (B) Oxidized crystal structure of human PDI (PDB ID:
4EL1). (C) Schematic of PDI domains present in the crystal structure, as well as the two
active site CXXC motifs. (Crystal structures created using Swiss PDBViewer). Image
taken from Khan, H. A., & Mutus, B. (2014). Frontiers in chemistry, 2.
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result in a higher percentage of the more reactive thiolate to form. This supports the
reasoning that the N-terminal cysteine reacts with the substrate first to form a mixed
disulfides (Walker & Gilbert, 1997). The high pKa of the C-terminal cysteine keeps the
majority as a thiol allowing for this cysteine to help with the release of the substrate
(Walker & Gilbert, 1997). This process is suggested to greatly help PDI from being
trapped in a mixed disulfide bond with a substrate (Walker & Gilbert, 1997). It is
hypothesized that PDI performs a “scanning and escape” mechanism, where after
forming a mixed disulfide PDI will scan for other thiols that are thermodynamically
stable to react with the substrate (Walker & Gilbert, 1997). If no thiol is available the Cterminal will help PDI “escape” from being trapped in a mixed disulfide with the
substrate (Walker & Gilbert, 1997). Interestingly, both the a and a’ domains contain a
lysine on the C-terminal end of the catalytic motif (CXXCK)(Edman et al., 1985).
The redox-inactive b and b’ domain has been identified to exhibit chaperone
activity (Denisov et al., 2009). Through NMR, the structure and amino acid residues of
the b’ domain were observed to interact with unfolded RNase A, an oft used enzyme to
assay the chaperone activity of PDI. The b’ domain contains a large multivalent
hydrophobic surface allowing for a structurally promiscuous binding site (Denisov et al.,
2009). In addition, computational analysis indicates that the bb’ domains contain 4
cavities allowing for the possible binding of a variety of ligands (Fu, Wang, & Zhu,
2011). Recently human PDI was found to dimerize in vivo through the binding of bb’ (Ali
Khan & Mutus, 2014; Bastos-Aristizabal, Kozlov, & Gehring, 2014).
Recently was observed that the chaperone activity of PDI is regulated by its redox
status. The crystal structure of the four thioredoxin-like domains of PDI in both the
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reduced and oxidized forms were obtained (C. Wang et al., 2012). The oxidized form of
PDI, the active site of a and a’ are 40.3 Å apart and the thioredoxin domains abb’a’ were
all in the same plane (Figure 2B)(C. Wang et al., 2012). Whereas in the reduced state of
PDI the active sites are 27.6 Å (Figure 2A), and only abb’ are in the same plane where a’
is twisted 45º, illustrating that the oxidized state has a more open conformation allowing
for the entry of chaperone substrates and the reduced state has a closed conformation
inhibiting their entry (C. Wang et al., 2013). This further illustrates long range
conformational changes induced by redox status of the active sites and further suggests
redox regulation of chaperone activity (Ali Khan & Mutus, 2014).
1.2.3! PDI localization/protein interactions/physiological role
As stated above, PDI contains an ER retention sequence at the C-terminal (Edman
et al., 1985). PDI is highly expressed in the ER, where its concentration is estimated to
be in the millimolar range (L. Wang, Wang, & Wang, 2015). This high concentration
allows PDI to function as a catalyst for oxidative protein folding through its redox
activity. As well as function as a chaperone at stoichiometric concentrations on nascent
polypeptides as well as on improper folded proteins (L. Wang et al., 2015). As PDI
performs its redox activity within the ER, it is suggested that an oxidized a domain
catalyzes the oxidation of the reduced substrates and in the process becomes reduced
(Walker & Gilbert, 1997). The a domain is then subsequently oxidized by the a’ domain
back to a disulfide through intramolecular reactions (Araki et al., 2013). The re-oxidation
of the a’ domain is catalyzed by the protein endoplasmic reticulum oxidoreductin-1
(Ero1) in the process reducing O2 to produce H2O2 (Figure 3) (Ali Khan & Mutus, 2014;
Araki & Nagata, 2011). It is also worth noting that glutathione and glutathione disulfide
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Figure 3. The hypothesized regeneration of PDI by Ero1. The a domain of PDI oxidizes
the substrate. The now reduced a domain is re-oxidized by the a’ domain. The now
reduced a’ domain is re-oxidized by Ero1. The thiols of Ero1 are oxidized by O2.
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(GSH/GSSG) can also oxidize and reduce the a and a’ domain (Ali Khan & Mutus,
2014). As a chaperone PDI as been observed to refold proteins such as glyceraldehyde-3phosphate dehydrogenase, rhodanese, citrate synthase, and alcohol dehydrogenase
(Wilkinson & Gilbert, 2004). It has also been observed that PDI can act as an antichaperone, where it can cause substrate protein-aggregation resulting in precipitation
(Wilkinson & Gilbert, 2004).
As previously stated, PDI is shown to be secreted to the cell surface of multiple
cell types (Turano, Coppari, Altieri, & Ferraro, 2002). Many studies have shown that cell
surface PDI plays a role in platelet activation (Ali Khan & Mutus, 2014; Turano et al.,
2002). Thiols on the surface of platelets play a critical role in intergrin-mediated platelet
adhesion, where PDI is required for the reduction and reshuffling of disulfide bonds
(Turano et al., 2002). Overall, PDI has been observed to play multiple roles in blood clot
formation (Ali Khan & Mutus, 2014; Cho, 2013; Flaumenhaft, 2013). Cell surface PDI
has also shown to play a role in nitric oxide signalling (Ali Khan & Mutus, 2014;
Ramachandran, Root, Jiang, Hogg, & Mutus, 2001). Cell surface PDI was observed to
release NO from S-nitrosylated glutathione (GSNO), one of the main nitric oxide carriers
in tissues (Root, Sliskovic, & Mutus, 2004). PDI would denitrosylate GSNO when NO
levels were low, however during high levels of NO, PDI would act as a carrier either
through the formation of SNO-PDI (Ali Khan & Mutus, 2014; Sliskovic, Raturi, &
Mutus, 2005).
Within liver cells, PDI is observed to be present in high quantities in the cytosol
(Turano et al., 2002). PDI is proposed work as an insulin degrading enzyme, where it
degrades insulin through the reduction of its disulfide bonds (Turano et al., 2002). In the
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nucleus, PDI is observed to affect the activity of transcription factor E2A. As well PDI
has been observed to interact with estrogen receptors to help with DNA binding (Turano
et al., 2002).
1.2.4! Catalytic activity assays for PDI
Since PDI has multiple functions, there are many diverse assays to detect these
activities. Each assay will only detect one of the four functions of PDI. Majority of the
assays for the PDI isomerase activity, deal with gain-of-function of an inactive protein
that contains incorrectly formed disulfide bonds (Watanabe, Laurindo, & Fernandes,
2014). The two main proteins used for isomerase activity assays are scrambled RNase
and riboflavin-binding protein (Watanabe et al., 2014). With scrambled RNase, the
addition of PDI will result in refolding to the native structure of RNase (Watanabe et al.,
2014). As RNase refolds, it will start to hydrolyze cyclic cytidine monophosphate, which
can be detected by absorbance (El Hindy et al., 2013; Lyles & Gilbert, 1991; Watanabe et
al., 2014).
Oxidation assays can be performed similar to isomerase assays where gain-offunction is observed. Another possible assay to detect oxidative folding is to trap
intermediates of oxidative folding by PDI using thiol alkylating agents, followed by mass
spectrometry (Watanabe et al., 2014). For chaperone activity, again gain-of-function
assays can be used, ensuring that proteins-substrates do not have disulfides in native
conformation i.e. glyceraldehyde-3-phosphate dehydrogenase (Cai et al., 1994; Watanabe
et al., 2014).
The most common reduction assay is the reduction of insulin by PDI resulting in
the precipitation of insulin (Watanabe et al., 2014). The turbidity of the solution can be
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monitored to determine reductase activity of PDI (Holmgren, 1979; Watanabe et al.,
2014). However, for this assay the lag time for precipitation to start and the rate of
precipitation must be taken into account (Watanabe et al., 2014). Another reductase assay
produced by our research group, uses GSSG where eosin-isothiocyanate, a fluorescent
molecule, is covalently bonded to the two amine groups, it is known as dieosin
glutathione disulfide (Di-E-GSSG) (Figure 4)(Raturi & Mutus, 2007). Di-E-GSSG is not
fluorescent due to the close proximity of the eosin moieties resulting in self-quenching.
When PDI is present the disulfide bond is reduced resulting in two eosin glutathione
(EGSH) molecules, which are fluorescent (Raturi & Mutus, 2007). The reduction of DiE-GSSG to EGSH results in a ~70 fold increase in fluorescence. This assay requires low
amounts of dithiothreitol (DTT), a thiol reducing agent, to re-reduce the PDI active site
thiols. DTT at the concentrattions employed (~50 µM) agent does not reduce Di-E-GSSG
(Raturi & Mutus, 2007). This assay only requires nanomolar amounts of PDI, which
makes this the most sensitive assay for PDI reductase activity to date.
1.3! Acetyltransferases
The transfer of an acetyl moiety from acetyl-CoA to the ε-amino group of a lysine
was first observed in 1960 on histones (Marmorstein, 2001). This reversible posttranslational modification results in the neutralization of the lysine as well as impairs
hydrogen bonding and creates a bulkier side chain (Figure 5) (Dormeyer, Ott, &
Schnolzer, 2005; Lee & Workman, 2007; Patel, Pathak, & Mujtaba, 2011). The enzymes
that catalyze this reaction are termed acetyltransferase. At first this modification was
thought to occur only on histones, however recently, non-histone proteins were observed
to be acetylated (Pehar & Puglielli, 2013). It was believed that protein acetylation could

11

Figure 4. Fluorogenic Di-E-GSSG reductase assay. A) Structure of Di-E-GSSG. B)
Reduction mechanism of Di-E-GSSG by PDI to produce the fluorescent EGSH. C)
Fluorescent graph of reductase assay, where DTT demonstrates little increase in
fluorescence. With the addition of PDI, fluorescence increases.
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Figure 5. Lysine acetylation by acetyltransfersase and acetyl-CoA.
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only occur in the nucleus and cytosol since that was the only area where it was observed.
However recently protein acetylation was observed in the mitochondria, and more
recently in the ER (Pehar & Puglielli, 2013).
There are three main families of acetyltransferases; MYST, p300/CBP, and Gcn5related N-acetyltransferase (GNAT)(Spange, Wagner, Heinzel, & Kramer, 2009). The
MYST protein family is named after four members of the family; MOZ, Ybf2, Sas2, and
Tip60 (Marmorstein, 2001). This protein family has sequence similarities at the acetylCoA binding motif with the GNAT family (Aka, Kim, & Yang, 2011). The p300/CBP do
not have this acetyl-CoA binding motif and do not share sequence similarities with
GNAT family or MYST family (Aka et al., 2011). The protein p300 appears to have a
very broad substrate acetyltransferase. The GNAT family is the largest acetyltransferase
family, containing proteins such as p300/CBP-associated factor (PCAF) and general
control nonrepressed 5 (Gcn5)(Aka et al., 2011). This family all posses four conserved
sequence motif known as C, D, A, and B (Pehar & Puglielli, 2013).
The only two acetyltransferases observed in the ER belong to the GNAT family
of acetyltransferases. These two proteins known as ATase1 (also known as Nacetyltransferase 8B) and ATase2 (also known as N-acetyltransferase 8) are also
members of the camello family (Pehar & Puglielli, 2013). These protein are differentially
expressed in a variety of cells. Interestingly in vitro experiments show that ATase 1
undergoes auto-acetylation, whereas ATase2 does not auto-acetylate (Pehar & Puglielli,
2013). It is important to remember that acetylation requires acetyl-CoA, which therefore
means that acetyl-CoA must be transported into the ER. Experiments have revealed that
there is a carrier-mediated transporter of acetyl-CoA on the ER membrane, where CoA
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moiety is the detection signal (Pehar & Puglielli, 2013). There have only been two
observed acetyltransferases in the ER, however it is likely that there are other ER-based
acetyltransferases (Pehar & Puglielli, 2013). Recently, a proteomic study was conducted
to discover all ER acetylated proteins (Pehar, Lehnus, Karst, & Puglielli, 2012). Over
100 proteins were identified to be ER acetylated proteins, by confirmation through mass
spectrometry (Pehar et al., 2012). PDI was one of these proteins signifying that
acetylation may regulate PDI activity. It was observed that lysine at the a’ domain
(K401) was observed to be acetylated. This sparked our interest, as a possible posttranslational modification to regulate PDI activity.
1.4! Research objectives
Very little research has been conducted on the regulation of PDI. The goal of this
project is to determine whether reductase activity is affected by a PDI-acetylation and to
identify the regulatory lysine residues in the enzyme. PDI acetylation will be investigated
by an acetyltransferase (PCAF) as well as by chemical acetylation by acetic anhydride.
The candidate lysine residues are those flanking the active site motif of PDI. Mutant
variants of these two lysines will be produced to see their effects on the reductase activity
of PDI. Mass spectrometry will be used in conjunction with activity assays to identify the
sites of actelylation.
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2! Materials
2.1! Chemicals
•! Tryptone, and yeast extract were purchased from Bio Basic Inc.
•! Sodium phosphate dibasic, sodium phosphate monobasic, glycerol, sodium
chloride, and sodium carbonate were purchased from ACP Chemicals Inc.
•! Dithiothreitol was purchased from MP Biomedical.
•! Bis-acrylamide solution, and Bio-Rad Protein Assay were purchased from BioRad.
•! Tris hydrochloride, dimethyl sulfoxide (DMSO), sodium dodecyl sulphate, Tris
base, potassium phosphate dibasic, potassium phosphate monobasic, kanamycin,
bromophenol blue, ammonium persulfate, ammonium bicarbonate, and agarose
were purchased from Fisher Scientific.
•! Acetic anhydride, sodium butyrate, imidazole, boric acid, sodium acetate, sodium
azide, Triton X100, bovine serum albumin, lysozyme, ethylenediaminetetraacitic
acid (EDTA), isopropyl β-D-1-thiogalactopyranoside (IPTG), Coomassie Brilliant
Blue R, deoxyribonuclease I from bovine pancreas (DNase I), trifluoroacetic acid,
α- cyano-4-hydroxycinnamic acid, phenylmethanesulfonyl fluoride (PMSF),
diethylenetriaminepentaacetic acid (DTPA), His SelectTM Nickel Affinity gel,
Glutathione–Agarose,

chloramphenicol,

reduced

glutathione,

glutathione

disulfide, 5,5'-dithiobis-(2-nitrobenzoic acid), Sephadex G-25, bicinchoninic acid,
copper(II) sulfate pentahydrate, guanidine hydrochloride, nickel(II) sulphate,
TEMED, and Phenol:Chloroform:Isoamyl alcohol25:24:1 were purchased from
Sigma-Aldrich.
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•! ZebaTM spin desalting columns was purchased from Thermo Scientific.
•! Plasmid Mini Kit was purchased from Qiagen.
•! Trypsin and Glu-C mass spec grade were purchased from Promega.
•! Bacteriological agar was purchased from Quelab.
•! PageRuler Plus Prestained Protein Ladder, GeneRuler 1 kb DNA Ladder, and
Eosin-5-Isothiocyanate were purchased from Life Technologies.
•! Magnesium chloride was purchased from BDH VWR analytical.
•! Q5® Site-Directed Mutagenisis Kit, NEB 5-alpha competent cells, PvuII, AvaI,
AvaII, NaeI, NotI, SmaI SacI, XmnI, and EcoRI were purchased from New
England BioLabs.
•! BL21 DE3 pLys competent cells was purchased from EMD Millipore.
2.2! Plasmids and primers
•! The pEt22b plasmid containing recombinant human PDI was created by Dana
Seslija.
•! The pGEX-2T plasmids containing GST-PCAF-HAT was kindly donated by Dr
David LeBrun from Queens University.
•! All primers were made by Intergrated DNA Technology:
o! Reverse PDI a domain primer:
5’AGGGGCCAGAGCCGCGCAGTGGCCACACCAAGG3’
o! PDI Lys-Ala a domain primer:
5’AGGGGCCAGAGCCGCGCAGTGGCCACACCAAGG3’
o! PDI Lys-Gln a domain primer:
5’AGGGGCCAGAGCCTGGCAGTGGCCACACCAAGG3’

17

o! PDI Lys-Glu a domain primer:
5’AGGGGCCAGAGCCTCGCAGTGGC3’
o! Reverse PDI a’ domain primer:
5’CCATGGGGCATAGAATTCCACAAAGAC3’
o! PDI Lys-Ala a’ domain primer:
5’TGTGGTCACTGCGCACAGTTGGCTCCC3’
o! PDI Lys-Gln a’ domain primer:
5’TGTGGTCACTGCCAACAGTTGGCTCCC3’
o! PDI Lys-Glu a’ domain primer:
5’TGTGGTCACTGCGAACAGTTGGCTC3’
o! Reverse PDI cysteine 295 primer:
5’TCAGGCCAAAGAACTCTAGGATGCG3’
o! Forward PDI cysteine 295 to serine primer:
5’AGAAGGAAGAGTCCCCGGCCGTGCG3’
o! Reverse PDI cysteine 326 primer:
5’TCCTCTCTGCCGTGAGCTCCTCCGATTC3’
o! Forward PDI cysteine 326 to serine primer:
5’TCACAGAGTTCTCCCACCGCTTCCTGGA3’
2.3! Equipment
•! Bio-Rad; PowerPacTM High current power supply, electrophoresis chamber, MiniSub® cell GT cell, T100TM Thermal Cycler, and Fraction Collector Model 2110.
•! Fisher Scientific; Model 100 Sonic Dismembrator.
•! Perkin Elmer; Wallac 1420 Victor 3 Fluorescent Plate Reader.
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•! PGC Scientifics; Type 37900 Culture Incubator.
•! Thermo Electron Corp; Orion Model 420A pH Meter, and Centrifuge Jouan
BR4i.
•! Alpha Innotech Corporation; AlphaImager® serial number 200018.
•! Agilent Technologies; Agilent 8543 UV-VIS Spectrophotometer, and Varian
Cary Eclipse Fluorescence Spectrophotometer.
•! New Brunswick Scientific; C25 Incubator Shaker.
•! EMD Millipore; 30kDa Amicon Ultra-15 Centrifugal Filter Units.
•! Molecular Devices; SpectraMax® Plus 384 Absorbance plate reader.
•! Labconco; Freeze dry system/Freezone 4.5.
•! Beckman Coulter; Beckman J2-HS centrifuge.
•! Applied Biosystems; Voyager-DE Pro Workstation mass spectrometry.
•! Hettich Zentrifuge; EBA-12 centrifuge.
•! Mettler Toledo; AJ100 analytical balance.
•! Ohaus; Scout Pro balance.

19

3! Methods
3.1! Plasmid bacterial transformation
The protocol used was obtained from Q5® Site-Directed Mutagenisis Kit
Protocol from New England BioLabs with minor changes. BL21, NEB 5-alpha, or Gold
competent cells were thawed on ice. Approximately 1-50ng of plasmid was then added to
20µL of competent cells and was mixed by flicking. Competent cells were returned onto
ice for 30 minutes. Competent cells were then heat shocked by incubating cells in 42˚C
water bath for 30 seconds. Cells were returned to ice and incubated for 2 minutes. The
SOC outgrowth medium was added to cells and then incubated in the C25 Incubator
Shaker at 37˚C for 60 minutes at 220 rpm. After incubation 100µL of cells were plated on
either LB agar plates (Gold and NEB 5-alpha) or 2xYT agar plates (BL21) and incubated
overnight at 37˚C. After incubation colonies were picked and added to LB or 2xYT
media. The culture was then incubated overnight where either mini-prep or protein
purification was performed.
3.2! Bacterial mini prep
The Qiagen Mini Prep protocol was used with some modifications to the protocol.
After plasmid transformation, 1.5 mL of culture was centrifuged for 1 minute at
12000 x g. The medium was then aspirated in order to obtain a dry pellet. The pellet was
re-suspended with 100µL of Buffer P1(50mM glucose, 25 mM Tris HCl, 10mM EDTA)
from the Qiagen Mini Kit. Qiagen Mini Kit Buffer P2 (0.2N NaOH, 1% SDS), 250µL
was added and was mixed by inversion. This was followed by 150µL of Buffer P3(3M
sodium acetate pH 5.2) from the Qiagen Mini Kit was again mixed by inversion. The
sample was then centrifuged at 12000 x g for 30 minutes at 4˚C. Phenol:chloroform,
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400µL was added to the supernatant. The mixture was then vortexed and centrifuged at
12000 x g for 1 minute at room temperature. The top aqueous phase was collected and
800µL of ice cold 95% ethanol was added. The sample was then vortexed and centrifuged
at 12000 x g for 10 minutes at 4˚C. The supernatant was decanted and 400µL of ice cold
70% ethanol was added to the pellet, which was then centrifuged at 12000 x g for 1
minute at room temperature. The supernatant was decanted and the pellet was air dried in
an inverted position for 10 minutes, re-suspended in 30µL of TE buffer (10mM Tris,
1mM EDTA pH 8) containing 20µg/mL of RNase A and incubated at 37˚C for 15
minutes. At this point the plasmid was either used for further experiments or frozen at
-80oC.
3.3! Site-directed mutagenesis
The Q5® Site-Directed Mutagenesis Kit protocol was used with minor changes.
The primers were designed to be end-to-end where the forward primer contained the
mutation and the reverse primer resulted in the gain or loss of a restriction enzyme digest
site. The PCR mix contained 6.25µL of the Q5 Hot Start High Fidelity 2x Master mix,
0.625µL of the forward and reverse primer, 0.5µL of the template plasmid, and 4.5µL of
nuclease-free water. Using the T100TM Thermal Cycler the cycling condition were set
according to Q5® Site-Directed Mutagenisis Kit. The initial denaturation step occurs at
98˚C for 30 seconds. The amplification cycle was repeated for 25 cycles of first a 10
second denaturing step at 98˚C. This was followed by 30 seconds of annealing at a
temperature between 50˚C and 72˚C depending on the primers used. The annealing
temperatures were calculated by the addition of 3˚C to the melting temperature of the
primer. The elongation step occurred next for 30 seconds at 72˚C. After the 25 cycles, a
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final step of elongation occurred for 2 minutes at 72˚C. After PCR, 1µL of the PCR
product was treated with 1µL of a kinase, ligase, DpnI mixture, 5µL of the reaction
buffer, and 3µL of nuclease-free water. This mixture was mixed by pipetting and kept at
room temperature for 5 minutes, where bacterial transformation followed.
3.4! Protein purification
3.4.1! His-Tagged PDI protein purification
The protein purification of PDI followed the same protocol of Raturi et al. with
some modifications (Raturi & Mutus, 2007). The expression of human PDI in pEt22b
plasmid was transformed in E. coli BL21. Cells were grown in 2xYT (tryptone, yeast
extract, and sodium chloride) with antibiotics (10µg/mL kanamycin A, 25µg/mL
chloramphenicol) at 37°C until the OD600 reading was between 0.4 – 0.6. Expression of
plasmid was induced with 1mM isopropyl β-D-1-thiogalactopyranoside and the cells
were incubated for 4 hours. Centrifugation of the cells were centrifuged at 6000 rpm for
30 minutes at 4°C and re-suspended in lysis buffer (1mM sodium chloride, 50mM Tris
hydrochloride (pH 8), 100µg/mL lysozyme, 50µg/mL DNase I, 2mM PMSF, and 1%
Triton X100) for 30 minutes on ice. The mixture was sonicated with a Fisher Scientific
Model 100 Sonic Dismembrator at a power level of 4, for 8 pulses, 20 seconds in
duration. The lysate was centrifuged at 10000 rpm at 4°C for 30 minutes. The supernatant
was applied to the His Select® Nickel Affinity column that was equilibrated with wash
buffer (10mM imidazole, 50mM sodium phosphate, 150mM sodium chloride pH 8). The
column was washed with 3 column volumes of wash buffer. Elution buffer (250mM
imidazole, 50mM sodium phosphate, 150mM sodium chloride pH 8) was then used to
elute the protein of interest. The protein sample was reduced using 1M of DTT. Buffer
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exchange was then performed on the protein fractions with a 30kDa Amicon Ultra-15
Centrifugal Filter Unit exchanging with 100mM phosphate buffer (100µM DTPA pH
7.4). Protein concentration was determined using the BCA assay where bovine serum
albumin was used as the standard. Protein purity was determined by a 10% SDS-PAGE
and stained with Coomassie Brilliant Blue.
3.4.2! GST-Tagged protein purification
The expressions of GST-tagged proteins in the pGEX-2T plasmids were
transformed into E. coli BL21. Cells were grown in 2xYT (tryptone, yeast extract, and
sodium chloride) with antibiotics (10µg/mL ampicillin, and 25µg/mL chloramphenicol)
at 37°C until the OD600 reading was between 0.4 – 0.6. Expression of plasmid was
induced with 1mM isopropyl β-D-1-thiogalactopyranoside and the cells were incubated
for 4 hours. The lysate was centrifuged at 10000 rpm for 30 min at 4°C. The cells were
then re-suspended in lysis buffer (1mM sodium chloride, 50mM Tris hydrochloride (pH
8), 100µg/mL lysozyme, 50µg/mL DNase I, 2mM PMSF, and 1% Triton X100) for 30
minutes on ice. The cells were then sonicated with the tip of a Fisher Scientific Model
100 Sonic Dismembrator at a level of 4, for 8 pulses, 20 seconds in duration. The lysate
was centrifuged at 10000 rpm for 30 min at 4°C. The supernatant was applied to a
glutathione-agarose column, followed by 4 column washes of the resin with PBS-T
(10mM phosphate buffer, 150mM sodium chloride, 1% Triton X100, pH 7.4). The
protein of interest was then eluted with elution buffer (10mM reduced glutathione, 50mM
Tris-HCl, pH 9.5). Buffer exchange was then performed with a 30kDa Amicon Ultra-15
Centrifugal Filter Units with 100mM phosphate buffer (100µM DTPA pH 7.4). Protein
concentration was determined using the BCA assay where bovine serum albumin was
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used as the standard. Protein purity was determined by 10% SDS-PAGE and stained with
Coomassie Brilliant Blue.
3.5! Di-Eosin-Glutathione Disulfide (Di-E-GSSG) synthesis
Di-E-GSSG was synthesized as per Raturi et al. with some minor modifications
(Raturi & Mutus, 2007). In a 50mL conical tube, 20mg of glutathione disulfide was
dissolved with 1mL of 100mM ammonium bicarbonate buffer (2mM EDTA, pH 9). A
2.5 molar excess of eosin-5-isothiocyanate was weighed out in the dark and dissolved in
2mL of DMSO. The solution of eosin-5-isothiocyanate was slowly added to the 50mL
conical tube containing glutathione disulfide while it was being vortexed at a low setting.
The solution was brought to a total volume of 10mL with 100mM ammonium
bicarbonate buffer. The reaction was incubated at 4˚C overnight on a nutating mixer. The
reaction was then quickly frozen by rotating the conical tube in a dewar of liquid
nitrogen. The sample was then lyophilized overnight, where the remaining solid was
dissolved with 1mL of milli-Q water. The 1mL of lyophilized sample was then applied to
a sephadex G-25 column containing 50mL of resin, which was equilibrated with 10mM
phosphate buffer (2mM EDTA, pH 7.4). Using a fraction collector, 180 fractions were
collected each containing 1mL of eluate. Fractions are then tested to observe amount of
fluorescent fold increase, by obtaining 20µL of the fraction and adding 1M of DTT in a
96-well plate. The increase in fluorescence was monitored at a wavelength of 545nm with
an excitation wavelength of 525nm. Fractions that showed a >30 fold or increase in
fluorescence were pooled. The concentration of the Di-E-GSSG was obtained from the
extinction coefficient of eosin (176000M-1·cm-1 at 525nm. Di-E-GSSG solution was then
divided into small aliquots and stored at -80˚C.
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3.6! Quantification of Eosin Reduced Glutathione (EGSH)
Known concentration of Di-E-GSSG were reduced with 5M DTT and incubated
for 30 minutes at room temperature to produce 2 EGSH. The fluorescence of the samples
was measured at 545nm (ex 525nm) and a standard curve of fluorescence vs. [EGSH]
was generated. This standard curve was used to quantify the concentration of EGSH that
was produced from the PDI-mediated reduction of Di-E-GSSG.
3.7! Determination of PDI concentration through burst kinetics
The concentration of PDI and the lysine variants were determined through burst
kinetics. The experiment consisted of 10µL of enzyme that was reacted with 800nM of
Di-E-GSSG in 100mM phosphate buffer (pH 7.4, 100µM DTPA) for 10 minutes. The
reaction was excited at 525nm and the fluorescence was monitored at 545nm. The linear
regression was obtained after the burst phase, where the y-intercept corresponds to the
amount of enzyme. Using the EGSH standard curve the concentration of enzyme was
determined.
3.8! PDI kinetic assay
The protocol for PDI reductase activity assay was obtained from Raturi et al. with
some minor modifications (Raturi & Mutus, 2007). The buffer used for all kinetic activity
assays was 100mM phosphate buffer containing 100µM DTPA at pH 7.4. The buffer was
filtered using a 0.2µm filter, degassed and purged with argon gas. Using the Varian Cary
Eclipse Fluorescence Spectrophotometer, 20µM of PDI or mutant PDI was added to
varying concentration of Di-E-GSSG (5nM-6000nM) in the presence of 10µM DTT. The
sample was excited with 525nm light and the fluorescence monitored at 545nm. For the
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pH titrations of PDI, the concentration of Di-E-GSSG was kept at 400nM and the pH
varied from 5.5 to 7.5. All kinetic assays are performed in triplicates.
3.9! PDI acetylation
3.9.1! PDI Acetylation by acetyltransferase
The protocol for in vitro acetylation was taken from Ogryzko et al. with some
changes(Ogryzko, Schiltz, Russanova, Howard, & Nakatani, 1996). The amount of the
acetyltransferases, (PCAF) used for the acetylation of PDI was in a 2:1 molar ratio.
Where 300pmol of PDI and 600pmol of acetyltransferase were dissolved in 500µL of
acetylation buffer. The acetylation buffer consisted of 50mM Tris hydrochloride pH 8,
50mM sodium chloride, 2.5mM magnesium chloride, 10mM sodium butyrate, 10%
glycerol, 0.5mM PMSF, 0.5mM DTT, and 6nM of acetyl-CoA, where DTT and acetylCoA are added fresh to the buffer before use. The reaction proceeded for 2 hours at 30˚C
on a nutating or rotating mixer. PDI was then isolated by using the His Select® Nickel
Affinity trial purification protocol found on the product information sheet. All eluate was
kept to determine any loss of PDI by running the samples on a 10% SDS-PAGE. The
isolated PDI was then buffer exchanged using ZebaTM spin desalting columns. The
modified PDI sample was then frozen and kept for mass spectrometry.
3.9.2! PDI acetylation by acetic anhydride
Acetic anhydride was used for the chemical acetylation of lysines on PDI. 4µmol
of PDI was reacted with either 8µmol or 40µmol of acetic anhydride. The reaction was
incubated at 4˚C for 2 hours on a rotating mixer. After incubation the modified PDI was
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then buffered exchanged using using ZebaTM spin desalting columns. The modified PDI
sample was then frozen and kept for mass spectrometry or kinetic assays.
3.10! Mass spectrometry analysis of PDI
PDI samples were digested using Glu-C for analysis on MALDI-TOF (VoyagerDE Pro Workstation mass spectrometry) and LC-MS. A 10:1 protein to protease by mass
ratio was maintained for all digests. PDI was digested overnight at room temperature.
The samples were then cleaned following manufacture’s protocol, and spotted with a 1:1
ratio of 10mg/mL of matrix solution (α-cyano-4-hydroxycinnamic acid in 60%
acetonitrile, 0.1% trifluoroacetic acid). The digests were analyzed by matrix assisted laser
desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Tandem mass
spectrometry (MS/MS) was performed on active site parent ions and compared to
sequence

fragments

predicted

by

Protein

Prospector

Software

(http://prospector.ucsf.edu/).
3.11! Computational analysis
In collaboration with Dr. Gaulds Group, computational analysis was performed on
PDI, the lysine variants and acetylated PDI. The enzymes structures were determined as
well as the pKa of the cysteine residues at the active site were calculated.
3.12! Statistical analysis
The kinetic analysis was performed by fitting the data to the Michaelis-Menten
equation:
!=

#$%& × (
)$ + (
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Excel was used to fit the data to solve for the enzyme kinetic parameters, KM, and VMax.
To determine statistical significance, an unpaired student t-test was used, where P<0.05
was taken as being statistically significant.
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4! Results
4.1! Reductase activity of PDI and PDI-Mutants, at physiological pH
Only one study has been conducted on the importance of the lysine residues flanking the
active site (K57 and K401)(Kimura et al., 2004). This study suggested that these lysine
residues play an important role for optimal PDI activity. Recently, our laboratory
investigated the potential role of these lysine residues in the regulation of PDI activity,
specifically through acetylation. Initially site-directed mutagenesis was performed on the
lysine residues to obtain 9 different variants of PDI. The lysine residues at the active sites
(K57 and K401) were either mutated individually or together to an alanine, glutamine, or
glutamic acid (summarized in Table 1).
Before reductase assays were performed, the concentrations of enzymes were
normalized through burst kinetics (Figure 6). The reaction consisted of Di-E-GSSG
(800nM) and enzyme (10µL) in 100mM phosphate buffer (pH 7.4, 100µM DTPA). The
increase of fluorescence was observed for 10 minutes, where the burst phase occurred in
the first minute. The linear regression was obtained after the burst phase, where the yintercept indicated the concentration of enzyme.
Steady-state kinetic parameters for the reductase activity of PDI and its lysine variants
were determined by a fluorogenic assay using Di-E-GSSG as the substrate (50 nM – 4000
nM). The experiments were conducted at pH 7.4. A low concentration of DTT (10µM)
was added to the buffer to reduce the enzyme. The baseline for the experiments was taken
as the rate of reduction of Di-E-GSSG by DTT. The concentration of EGSH was
calculated from a standard plot. The data for PDI and its lysine variants were fitted to the
Michaelis-Menten equation (Figure 7). The Michaelis-Menten kinetic parameters (KM
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Protein

a Domain

a’ Domain

wt-PDI

CGHCK

CGHCK

PDI K-Q aa’

CGHCQ

CGHCQ

PDI K-Q a

CGHCQ

CGHCK

PDI K-Q a’

CGHCK

CGHCQ

PDI K-A aa’

CGHCA

CGHCA

PDI K-A a

CGHCA

CGHCK

PDI K-A a’

CGHCK

CGHCA

PDI K-E aa’

CGHCE

CGHCE

PDI K-E a

CGHCE

CGHCK

PDI K-E a’

CGHCK

CGHCE

Table 1. A summary of all site-directed mutations performed on PDI. All
K-E mutations were performed by Cody Caba in completion of his
Honours Thesis research project.
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Figure 6. Burst kinetics for wt-PDI and mutants. For each experiment,
10 µL of enzyme was reacted with 800 nM of Di-E-GSSG for 10
minutes. The linear regression was taken after the burst phase, where the
y-intercept indicated the concentration of enzyme. All kinetics for K-E
mutations (H, I, and J) were performed by Cody Caba as a part of his
Honours Thesis research project.

31

A

B

C

D

E

F

G

H

I

Figure 7. Initial rate vs. [Di-E-GSSG] plots for PDI and mutants. For each experiment
the protein concentration was 20nM, and the initial rate was expressed as the amount of
EGSH produced (nM/s). The assay was performed with 10µM of DTT in phosphate
buffer (100mM phosphate pH 7.4, 0.1mM DTPA) and data was collected for 1 minute.
The dashed lines represent the application of the best-fit kinetic parameters, obtained
from the data, to the Michaelis-Menten equation. The error bars represent standard
deviation, n=3. All kinetics for K-E mutations (G, H, and I) were performed by Cody
Caba as a part of his Honours Thesis research project.
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and VMax) and catalytic efficiency (kcat/KM) were calculated for each protein and
presented in (Figure 8). The reductase assay indicated that any mutation at either or both
lysine residues (K57 and K401) results in a significant decrease (p<0.05) of VMax (Figure
8C). The majority of mutants had a decrease of approximately 50% of wild type VMax,
where PDI K-E aa’ had the lowest percentage of wild type VMax at 17%. This indicates
that a lysine residue provides maximum rate, and changing this residue to a negatively
charged amino acid like glutamic acid will drastically decrease the rate of the enzyme.
When comparing the KM of wt-PDI with all the glutamine mutants and PDI K-A a’ and
aa’ there was no significant difference observed (p<0.05) (Figure 8A). Interestingly, the
KM of PDI K-A a (333.04 ± 5.043 nM) was observed to be significantly lower (p<0.05)
than wt-PDI (435.96 ± 15.298 nM). Due to the fact that the glutamic acid mutations
would result in a reversal of charge from positive to negative it was not surprising that all
glutamic acid mutants displayed a significantly higher (p<0.05) KM when compared to
wild type. Interestingly, the catalytic efficiency for all lysine mutants was observed to be
significantly lower (p<0.05) than wt-PDI (5.10 ± 0.210 × 105 M-1s-1)(Figure 8B). The
mutant with the highest catalytic efficiency was PDI K-A a and PDI K-E aa’ had the
lowest catalytic efficiency. This further supports the notion that lysine is important for
optimal reductase activity.
4.2! The effect of the active site lysine residues on the pH optima of the reductase
activity of PDI
To further study the influence of active site lysine residues on PDI activity, a pH
titration was performed. This was to specifically determine whether the positive charge
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Figure 8. Michaelis-Menten kinetic parameters and catalytic efficiency (kcat/KM)for wtPDI and mutants at pH 7.4. The kinetic parameters and catalytic efficiency were
estimated by utilizing a fit of the initial rate data of EGSH production by wt-PDI and the
Lys variants by using the Solver function in MS Excel. Results are expressed as the mean
with standard deviation, n=3. Significant differences (p<0.05) are indicated by *. All K-E
mutation kinetics were performed by Cody Caba as a part of his Honours Thesis research
project.
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on the lysine residue affected the pKa of active site cysteine residues. For these
experiments, Di-E-GSSG was kept constant at 400nM, and the pH was varied between
5.5 - 7.5. The initial rates at varying pH values were plotted for each set of amino acid
mutant with wt-PDI (Figure 9). All of the lysine variants exhibited similar bell-shaped pH
titration curves in comparison to wild type. It was observed that PDI reductase activity
was most active at pH 6.5 and not physiological pH of 7.4 or the postulated pH of the
ER,7.2(Wu et al., 2000). It was observed (Figure 9) that all proteins displayed bellshaped curve where at pH 5.5 and 7.5 the initial rates were at their lowest, between
0.5nMs-1 to 1.5nMs-1. Interestingly, wt-PDI and the lysine to glutamine and alanine
variants all displayed similar initial rates at pH 6.
4.3! Reductase activity of wt-PDI and PDI mutants, at pH 6.5
Since pH 6.5 exhibited the highest initial rate for wt-PDI and all lysine variants
(Figure 9) the fluorogenic reductase activity assays were repeated at pH 6.5. At this pH of
6.5, a higher percentage of lysine residues would be protonated resulting in a positive
charge. Any possible acetylation of a lysine residue would neutralize the positive charge.
The initial rates of EGSH production from Di-E-GSSG (25nM – 1000nM) were fitted to
the Michaelis-Menten equation for wt-PDI and the lysine variants (Figure 10). The
Michaelis-Menten kinetic parameters (KM and VMax) and catalytic efficiency (kcat/KM)
were also calculated for each enzyme and presented in Figure 11. It was observed that
almost all lysine variants displayed a reduction in VMax, where only PDI K-Q aa’ did not
display a significant reduction (p<0.05)(Figure 11C). This further supports the notion that
lysine is critical for optimal activity. The lysine variants displayed greater variability in
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Figure 9. pH Titration curves of PDI and mutants. The concentration of wt-PDI was kept
constant at 20nM and Di-E-GSSG was kept constant at 400nM. The change in pH
occurred through the addition of NaOH. The rate was expressed as the amount of EGSH
produced (nM/s). Results are expressed as the mean with standard deviation, n=3. All
kinetics for K-E mutations (C) were performed by Cody Caba as a part of his Honours
Thesis research project.
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Figure 10. Initial rate vs. [Di-E-GSSG] plots for wt-PDI and mutants. For each
experiment the protein concentration was 20nM, and the initial rate was expressed as the
amount of EGSH produced (nM/s). The assay was performed with 10µM of DTT in
phosphate buffer (100mM phosphate pH 6.5, 0.1mM DTPA) and data was collected for 1
minute. The dashed lines represent the application of the best-fit kinetic parameters,
obtained from the data, to the Michaelis-Menten equation. The error bars represent
standard deviation, n=3. All kinetics for K-E mutations (G, H, and I) were performed by
Cody Caba as a part of his Honours Thesis research project.
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Figure 11. Michaelis-Menten kinetic parameters and catalytic efficiency (kcat/KM)for wtPDI and mutants. The kinetic parameters and catalytic efficiency were estimated from a
fit of the initial rate data of EGSH production at pH 6.5 by wt-PDI and the Lys variants
by using the Solver function in MS Excel. Results are expressed as the mean with
standard deviation, n=3. Significant differences (p<0.05) are indicated by *. All K-E
mutation kinetics were performed by Cody Caba as a part of his Honours Thesis research
project.
!

38

KM when compared to wt-PDI (119.63 ± 18.662 nM) (Figure 11A). Interestingly, PDI KQ aa’ (191.82 ± 31.416 nM) showed a significant increase (p<0.05) in KM. Also, as
shown at pH 7.4, all lysine to glutamic acid variants exhibited significant increases
(p<0.05) in KM. This suggests that these lysine variants lower the binding affinity of the
substrate to the protein. Interestingly, PDI K-A a’ (89.73 ± 12.866nM) exhibited a
significant reduction (p<0.05) in KM when compared to wt-PDI. Therefore, an alanine at
the C-terminal end of the CXXC motif in the a’ improves substrate binding. The catalytic
efficiency of PDI was calculated to be 2.78 ± 0.506 × 106 M-1s-1 (Figure 11B), which was
higher than previously reported for PDI reductase activity(Raturi & Mutus, 2007). Only
PDI K-Q aa’, PDI K-E aa’, PDI K-E a, and PDI K-E a’ exhibited significantly lower
(p<0.05) catalytic efficiency when compared to wt-PDI. This suggests these lysine
variants reduce the protein’s reductase activity, which further supports lysine as an
integral residue for PDI activity.
4.4! Computational structural and pKa analysis of active site cysteine residues
In collaboration with Dr. Gauld’s Group, computational calculations were
performed to estimate the pKa values for the active site cysteine residues (Li, Robertson,
& Jensen, 2005) as a function of the lysine mutations. Computational analysis was
performed on wt-PDI, the lysine variants, and on acetylated lysine residues (Table 2).
The N-terminal cysteine residues in PDI displayed a lower pKa (C53 – 4.45, C397 –
4.66), whereas the C-terminal cysteine residues had a higher pKa (C56 – 8.67, C400 –
9.81). These results were comparable to previously reported values for the pKa of the
cysteine residues (Karala et al., 2010; Nelson & Creighton, 1994). Interestingly, the
acetylated a domain cysteine residues showed similar pKa values to those of PDI K-E aa’
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Protein

C53 pKa

C56 pKa

C397 pKa

C400 pKa

PDI

4.45

8.67

4.66

9.81

PDI K-Q aa’

4.96

8.52

4.06

8.16

PDI K-A aa’

4.39

12.98

4.83

12.58

PDI K-E aa’

5.43

10.43

4.78

8.29

5.6

9.14

4.79

12.01

PDI Acetylated
(K57 and K401)
Table 2. Computationally estimated pKa’s of active site cysteines in the a and a’
domain. Wanlei Wei of Dr. Gauld’s group performed the computational analysis
of all the proteins (Li et al., 2005).
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in the a domain. Whereas, the acetylated a’ domain cysteine residues showed similar pKa
values to those of PDI K-A aa’ in the a’ domain. Through computational analysis, the
structure of the a’ domain active site was elucidated (Figure 12). The acetylated a’
domain active site was also determined through dynamic simulations for comparison
(Figure 13). It is noticeable from the acetylated active site that the lysine residue is
shifted towards the backbone of the enzyme, whereas the un-acetylated lysine is pointed
away from the active site cysteines. Also, it is noticeable that in the acetylated protein the
cysteine residue (C400) is further away from the glutamic acid residue (E391).
4.5! Identification of acetylated active site lysine residues through mass
spectrometry
The two active sites of PDI have similar sequences, which might be difficult to
differentiate between the two using mass spectrometry. However, a previous study that
used Glu-C as the protease for digestion was successful in identifying the two active sites
(Kozarova et al., 2007). Therefore, a similar protocol was used, where PDI was
proteolyzed by a 10:1 ratio of PDI to Glu-C. Digestion was performed overnight at room
temperature. The double His-tagged PDI (60kDa) digests were desalted then analyzed by
MALDI-TOF, and MS/MS was performed on active site parent ions for further
confirmation (Figure 14). The expected mass-to-charge ratio (m/z) for the active site
fragments was 1692.8 (a domain) and 2462.2 (a’ domain) as predicted by Protein
Prospector software. Surprisingly, fragment peaks appeared at m/z 1689.9 and 2459.6 and
not at the predicted m/z (Figure 14A). However, through MS/MS these fragment were
verified to be the active sites of PDI (Figure 14B and C).
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Figure 12. Computational dynamics simulation of wt-PDI a’ domain active site.
Distances are provided in Angstroms. The atoms are represented by colours (yellow:
sulfur, red: oxygen, blue: nitrogen, light grey: hydrogen, and dark grey: carbon).
Wanlei Wei of Dr. Gauld’s group performed the computational analysis of all the
proteins.
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Figure 13. Computational dynamics simulation of acetylated wt-PDI a’ domain
active site. Distances are provided in Angstroms. The atoms are represented by
colours (yellow: sulfur, red: oxygen, blue: nitrogen, light grey: hydrogen, and dark
grey: carbon). Wanlei Wei of Dr. Gauld’s group performed the computational
analysis of all the proteins.
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Figure 14. Mass fingerprint analysis of PDI Glu-C peptides. PDI digestion was
performed overnight at room temperature using a 10:1 ratio of PDI to Glu-C. A) The
mass fingerprint of PDI, where m/z 1689 and 2459 corresponds to the active sites of
PDI. B) The MS/MS of the m/z 1689 parent ion corresponding to the a domain of PDI.
C) The MS/MS of the m/z 2459 parent ion corresponding to the a’ domain of PDI.
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An acetyltransferase (PCAF) was used to perform acetylation on PDI. PDI was
reacted with PCAF and acetyl-CoA in a 1:2:20 ratio. After the reaction was incubated at
32˚C for 2 hours, PDI was isolated using the His Select® Nickel Affinity column. PDI
was then digested with Glu-C and analyzed on the MALDI-TOF. The active site
fragment peaks were observed at m/z 1690 and 2460 (Figure 15). However, no acetylated
fragment peaks were observed, which would appear at m/z 1734 and 2504.
Next, acetylation was performed chemically by acetic anhydride. PDI was reacted
with acetic anhydride in a 1:10 ratio, for 2 hours at 37˚C. PDI was desalted to remove
excess acetic anhydride and digested with Glu-C. The fragments were analyzed on the
MALDI-TOF. The active site fragment peaks were again observed at m/z 1691 and 2459
(Figure 16A). An acetylation peak was observed as well at m/z 2502, which is a 42Da
increase of the 2459 peak indicative of acetylation. This peak was further analyzed and
confirmed through MS/MS to be the acetylated a’ domain (Figure 16B). The MS/MS
suggests that lysine 401 has been acetylated by the presence of the b10 ion. This indicates
that the a’ domain active site lysine of PDI appears to be partially acetylated due to the
presence of both un-acetylated and acetylated peptides.
4.6! Reductase activity of un-acetylated and acetylated PDI and PDI K-Q aa’
Chemical acetylation of PDI and PDI K-Q aa’ was performed using acetic
anhydride. Acetylation was performed for 2 hours at 37˚C, where after incubation the
protein was desalted. The fluorogenic reductase assay Di-E-GSSG (25nM-1000nM) was
performed at pH 6.4 in phosphate buffer. The initial rates of EGSH production were fitted
to the Michaelis-Menten equation for both un-acetylated and acetylated protein (Figure
17). The Michaelis-Menten kinetic parameters (KM and VMax) and catalytic efficiency
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Figure 15. Mass fingerprint analysis of PDI reacted with acetyltransferase (PCAF). PDI
was incubated with PCAF and acetyl-CoA for 2 hours at 32˚C. PDI was the digested with
Glu-C overnight at room temperature. Only the un-acetylated peptide fragments are
observed in the mass fingerprint.
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Figure 16. Mass fingerprint analysis of PDI reacted with acetic anhydride. PDI was
incubated with acetic anhydride for 2 hours at 37˚C. PDI was the digested with Glu-C
overnight at room temperature. A) Un-acetylated peptide fragments are observed in the
mass fingerprint. The a’ active site domain is observed to be acetylated with a m/z
2502. B) The MS/MS of the m/z 2502 parent ion, which corresponds to the acetylated
active site a’ domain.
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Figure 17. Initial rate vs. [Di-E-GSSG] plots for un-acetylated and acetylated wt-PDI and
PDI K-Q aa’. For each experiment the protein concentration was 20nM, and the initial
rate was expressed as the amount of EGSH produced (nM/s). The assay was performed
with 10µM of DTT in phosphate buffer (100mM phosphate pH 6.5, 0.1mM DTPA) and
data was collected for 1 minute. The dashed lines represent the application of the best-fit
kinetic parameters, obtained from the data, to the Michaelis-Menten equation. The error
bars represent standard deviation, n=3.
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(kcat/KM) were calculated and presented in (Figure 18). Interestingly, the VMax of
acetylated PDI and PDI K-Q aa’ both significantly increased (p<0.05) indicating that
acetylation may increase the turnover rate (Figure 18C). However, for KM only the
acetylation of wt-PDI resulted in a significant increase (p<0.05) (Figure 18A). Whereas,
acetylated compared to un-acetylated PDI K-Q aa’ produced no significant change in KM.
This indicates that the acetylation at the active site lysine results in a decrease in affinity
to the substrate. Interestingly, acetylated wt-PDI was observed to significantly decrease
(p<0.05) catalytic efficiency in comparison to un-acetylated (Figure 18B). Whereas,
acetylated PDI K-Q aa’ was observed to significantly increase (p<0.05) catalytic
efficiency in comparison to un-acetylated. This suggests that acetylation at the active
lysine may inhibit the reductase activity, whereas acetylation at other lysine residues may
increase the reductase activity.
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Figure 18. Michaelis-Menten kinetic parameters and catalytic efficiency (kcat/KM)for wtPDI and mutants. The kinetic parameters and catalytic efficiency were estimated from a
fit of the initial rate data of EGSH production at pH 6.5 by wt-PDI and the Lys variants
by using the Solver function in MS Excel. Results are expressed as the mean with
standard deviation, n=3. Significant differences (p<0.05) are indicated by *.
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5! Discussion
5.1! The importance of active site-flanking lysine residues in the reductase activity
of PDI
Lysine residues play an important role to maintain protein structure and function,
through hydrogen bonds or electrostatic interactions (Patel et al., 2011). The role of PDI
active site-flanking lysines has not been well studied. In fact there is only one study to
our knowledge, which has been conducted on the importance of this residue in PDI
(Kimura et al., 2004). In the earlier study, the researchers mutated away the cysteine
residues in the a’ domain and focused on the lysine in the a domain (Kimura et al., 2004).
The lysine residue in the a domain was then mutated to glutamine and arginine, where a
decrease in activity was observed (Kimura et al., 2004). The assay used in this study
involved the reduction of insulin by PDI, which was monitored by spectrophotometry.
However, this study or any other studies to our knowledge have not delved into how
lysine residues affect the redox activity of PDI as well as how they may be used to
regulate PDI activity.
In the current study, lysine residues (K57 and K401) were mutated individually or
together to further investigate the role lysine plays at both the a and a’ domains. The
lysine residues were mutated to glutamine, alanine, or glutamic acid (Table 1). Glutamine
was chosen for the reason that it can form hydrogen bonds as well as it best mimics the
bulky characteristics of lysine while it provides a neutral charge. Lysine was mutated to
glutamic acid in order to observe the effects of PDI activity with a negative charge taking
the place of the positively charged of lysine residue. A small neutral amino acid such as
alanine was chosen to observe if flexibility at that site provides any change in activity of
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PDI. These mutations will provide further understanding of the role of lysine at the active
site of PDI.
The steady-state kinetic parameters observed at pH 7.4 provided vital information
of how lysine may play a role in PDI reductase activity (Figure 8). The KM of most lysine
variants showed very little change in comparison to wt-PDI (435.96 ± 15.298 nM). This
indicates that these mutations did not affect the binding of substrate to the enzyme. In the
case of the PDI K-A a domain, surprisingly displayed a significant decrease in KM
(333.04 ± 5.043 nM). This suggests that a more flexible amino acid at the a domain may
improve the accessibility of the substrate to the active site. However, all the glutamic acid
mutants demonstrated a significant increase in KM (Figure 8A). This may suggests that a
negative charge near the active site inhibits the initial binding of the substrate to the
active site.
It was observed that all lysine variants displayed a significant decrease in VMax
(Figure 8C). This suggests that any neutral or negatively charged amino acid will hinder
the turnover rate of the enzyme. Interestingly, as previously stated (Table 2), the pKa of
the two cysteines in the active site are quite different. The N-terminal cysteine is
observed to have a pKa around 4, which is hypothesized to form a thiolate and bind to the
substrate (Karala et al., 2010). The C-terminal cysteine is observed to have a pKa around
9, and it is hypothesized that the pKa of this cysteine will decrease in order to form a
thiolate and release the substrate from the N-terminal cysteine (Nelson & Creighton,
1994). From the VMax results, it is apparent that lysine plays a significant role in turnover
rate, where we postulate that the positive charge on the lysine may help reduce the pKa of
the C-terminal cysteine. The fact that all glutamic acid mutants demonstrated the lowest
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VMax values support this theory that the positive charge on lysine may help to reduce the
pKa of the C-terminal cysteine. The catalytic efficiency of the lysine variants were all
significantly lower than wt-PDI (Figure 8B). This suggests that lysine is needed for
optimal PDI activity.
In order to observe the effect that the lysine variants have on the pKa of the
cysteine residues, a pH titration was performed (Figure 9). Surprisingly, none of the
lysine variants caused a shift in the pH titration curve. All enzymes created a bell-like
curve, where PDI and all the lysine variants were most active at pH 6.5 (Figure 9).
Therefore, the steady-state kinetics on PDI and the lysine variants were repeated
at pH 6.5 (Figure 11). The kinetic parameters at pH 6.5 displayed some differences to the
kinetic parameters observed at pH 7.4. PDI K-Q aa’ displayed a significant increase in
KM, suggesting that Di-E-GSSG was inhibited from reaching the active site (Figure 11A).
This could be due to the fact that glutamine residues at the lower pH form more hydrogen
bonding and therefore results in a less accessible active site. Interestingly, at pH 7.4 PDI
K-A a (Figure 8A) demonstrated a lower KM. However, at pH 6.5 it is PDI K-A a’ that
exhibited a significant decrease in KM (Figure 11A). This could possibly suggests that a
change in pH would change which domain is more active. As previously observed at pH
7.4, glutamic acid mutants exhibited a significantly higher KM than wt-PDI at pH 6.5
(Figure 11A).
Unexpectedly, PDI K-Q aa’ exhibited no significant change in VMax compared to
wt-PDI (Figure 11C). It is possible that the increase in hydrogen bonding at the lower pH
resulted in a more rigid structure where the cysteine residues would more easily form
thiolates. This would result in a turnover rate that is larger than expected. All other lysine
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variants exhibited a significant decrease in VMax at pH 6.5 as previously seen at pH 7.4
(Figure 8C and Figure 11C). PDI K-Q aa’ and all the glutamic acid mutants displayed a
significantly lower catalytic efficiency compared to wt-PDI at pH 6.5 (Figure 11B).
However, the other lysine variants did not appear to have a significantly lower catalytic
efficiency compared to wt-PDI at pH 6.5 (Figure 11B). This could suggest that at a lower
pH, the efficiency of the enzyme is not fully predicated on a lysine residue being at the
active site. However it should be noted that wt-PDI (2.78 ± 0.506 × 106 M-1s-1) still
exhibited the highest catalytic efficiency and is higher than previously reported for
reductase activity (Raturi & Mutus, 2007).
5.2! The possible regulation of PDI by lysine acetylation
Recently, more extensive studies have been conducted in regards to lysine
acetylation; specifically on non-histone acetyltransferases (Marmorstein, 2004). Now, it
is understood that acetylation may play a role on an increasing number of proteins
throughout the cell (Pehar & Puglielli, 2013). In the recent proteomic study of all ER
acetylated proteins, PDI was observed to be acetylated, indicating the possible role as a
post-translation modification to regulate PDI activity (Pehar et al., 2012). It was observed
that PDI contains 7 sites of acetylation on PDI (Table 3) (Pehar et al., 2012).
Interestingly, the lysine residue flanking the active site at the a’ domain (K401) was
acetylated (Table 3)(Pehar et al., 2012). This further confirmed that the active siteflanking lysine residues may act as a possible regulator of PDI activity.
Through computational analysis performed by Dr. Gauld’s group, the pKa’s of the
cysteine residues at the active site were determined for the lysine variants as well as for
acetylated lysine residues (K57 and K401) on PDI (Table 2). The calculations revealed
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PDI Domain

Sequence

b’ domain

IKPHLMSQELPEDWDKQPVK

a’ domain

NVFVEFYAPWCGHCKQLAPIWDKLGETYK

b’ domain

ILEFFGLKK

a’ domain

NFEDVAFDEKK

a’ domain

DHENIVIAKMDSTANEVEAVK

Table 3. Sequences of acetylated peptides found in PDI through mass spectrometry.
Lysine residues in red font indicate acetylated residue. Information taken from
supplementary data of Pehar, M. et al. (2012). Journal of Biological Chemistry, 287(27).
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that a mutation or acetylation of those lysine residues would result in a change in pKa of
the active site cysteine residues (Table 2). This suggested that the lysine plays an
important role in maintaining the correct microenvironment for the cysteine residues. By
changing the charge as well as creating a bulkier group on lysine resulted in a change in
the microenvironment. It should be noted that acetylation of a lysine and glutamine,
which both contain a carbonyl group, could be an acceptor for hydrogen bonding.
Interesting changes occurred in the molecular dynamic simulations of the unacetylated and acetylated wt-PDI (Figure 12 and Figure 13). From the un-acetylated wtPDI (Figure 12) it was evident that the lysine residue (K401) was positioned away from
the active site of PDI. In the acetylated wt-PDI (Figure 13), the acetyl-lysine was shifted
towards the backbone of the active site. This could be caused by a potential hydrogen
bond between the carbonyl group of the acetyl moiety and the amino group of the
backbone. Interestingly, the C-terminal cysteine residue was observed to be in very close
proximity to a glutamic acid residue (E391). This could be the cause of the increase in
pKa of the C-terminal cysteine (Table 2), since a negatively charged residue will
influence the sulfur to be in a protonated state. In this reduced conformation of wt-PDI,
likelihood of reactive thiolate formation at the C-terminal cysteine would be decreased.
This further supports that substrate would bind to the N-terminal cysteine causing a
conformational change, which would result in the lowering of the pKa of the C-terminal
cysteine.
In the acetylated wt-PDI it was observed that the C-terminal cysteine is further
away from the glutamic acid residue by almost an Å of distance. This suggests that the
cysteine residue (C400) would have a lower pKa due to the fact that the sulfur is further
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away from a negative charge. However, though the computational analysis of the pKa’s
(Table 2), it was observed that the a’ domain C-terminal cysteine (C400) had an increase
in pKa. This was a surprising observation and suggests that further investigation is
required to understand how the C-terminal cysteine residue possesses a high pKa while
still maintaining reactivity. This also suggests that acetylation of the lysine residue
(K401) would result in a decrease in turnover rate of PDI because of the high pKa of the
C-terminal cysteine.
To further understand the affects of lysine acetylation on PDI, in vitro acetylation
was first performed by an acetyltransferase (PCAF). However, through mass
spectrometry it was determined that PDI was not acetylated by this enzyme (Figure 15).
PCAF is an acetyltransferase that is part of the GNAT family and is found primarily in
the nucleus (Gupta, Samant, Smith, & Shroff, 2008). The use of PCAF as an
acetyltransferase was based on the fact that it was accessible. It was assumed that the
acetylation of PDI by this acetyltransferase was unlikely to occur.
Since PCAF was not successful, a cruder acetylation process was performed using
acetic anhydride. This procedure has the potential non-specific acetylation of lysine
residues. When a 10:1 ratio of acetic anhydride to PDI was reacted, it was observed that
PDI became acetylated through mass spectrometry (Figure 16). The a’ domain was
confirmed to be acetylated through MS/MS of the m/z 2501 parent ion. The presence of a
42Da increase in the b10 ion from the un-acetylated PDI in comparison to the acetylated
PDI confirmed the presence of acetylation on the active site-flanking lysine residue
(K401) (Figure 14C and Figure 16B). However, it should be noted that the a’ domain
flanking lysine (K401) was not fully acetylated due to the presence of the m/z 2459
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(Figure 16A). Therefore, through mass spectrometry analysis it was determined that PDI
became partially acetylated by acetic anhydride and not by the acetyltransferase PCAF.
Steady-state kinetics were performed on un-acetelyated and acetylated wt-PDI
and PDI K-Q aa’ at pH 6.5 (Figure 17). PDI K-Q aa’ was used in addition to wt-PDI
because the amino acid glutamine more closely resembles lysine and the glutamine would
not be acetylated by acetic anhydride. The VMax of the acetylated enzymes displayed
significant increases in comparison to the un-acetylated enzymes (Figure 18C). The fact
that acetylation of both wt-PDI and PDI K-Q aa’ caused an increase, suggests that
acetylation of PDI at lysine residues that are not flanking the active site may assist in
enzyme turnover rate. This is an surprising result since the pKa analysis suggested that
acetylation at the active site-flanking lysine residue would result in an increase in pKa
and in effect decrease the turnover rate of the enzyme. However, it appears that
acetylation at other lysine residues overwhelms the predicted inhibitory effect that the
acetylated lysine at the active site provides.
Interestingly, the KM of acetylated wt-PDI (96.46 ± 8.236 nM) significantly
increased in comparison to the un-acetylated wt-PDI (52.13 ± 7.221 nM) (Figure 18A).
Whereas, there was no significant change in KM for acetylated PDI K-Q aa’ and
unacetylated PDI K-Q aa’ (Figure 18A). This possibly suggested that acetylation at the
active site-flanking lysine residues, specifically the a’ domain resulted in a decrease in
substrate binding to the active site. The fact that acetylated PDI K-Q aa’ did not change
significantly compared to un-acetylated PDI K-Q aa’, suggests that acetylation at other
lysine residues did not affect substrate binding to the enzyme.
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The catalytic efficiency of acetylated wt-PDI (1.41 ± 0.110 × 106 M-1s-1) was
significantly reduced in comparison to un-acetylated wt-PDI (1.76 ± 0.163 × 106 M-1s-1)
(Figure 18B). However, acetylated PDI K-Q aa’ (1.09 ± 0.048 × 106 M-1s-1) resulted in a
significant increase in catalytic efficiency in comparison to un-acetylated PDI K-Q aa’
(7.61 ± 0.471 × 105 M-1s-1) (Figure 18B). Interestingly, acetylation at the flanking active
site lysine residues may inhibit PDI activity through the inhibition of substrate binding
and not through the inhibition of product release. However surprisingly, PDI activity
surprisingly increased when acetylated at non-active site-flanking lysine residues, by
promoting the turnover rate.
It should be noted that acetylation by acetic anhydride may not reproducibly
acetylate the same lysine residue. This implies that these acetylation results should be
evaluated cautiously when making any implications into how acetylation affects PDI.
These acetylation experiments should be repeated to observe if reproducible. Also, since
wt-PDI was only partially acetylated by acetic anhydride at lysine residue 401, it could be
appropriate to repeat the experiments using an increased concentration of acetic
anhydride to fully acetylate the enzyme at the active site lysine. To accurately draw
conclusions about the role of acetylation on PDI, the reproducibility of this protocol must
be confirmed.
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6! Conclusion
The investigation into the role of PDI active site-flanking lysine residues suggests
that these lysine residues assist in PDI redox activity. The rational behind this is that all
lysine variants, with the exception of PDI K-Q aa’, resulted in a decrease in VMax. PDI KQ aa’ did not exhibit a significant decrease in VMax at pH 6.5, however it did exhibit this
at pH 7.4 (Figure 8C and Figure 11C). Additionally, the catalytic efficiency of all lysine
variants significantly decreased at pH 7.4(Figure 8C). At pH 6.5 all lysine variants had a
decrease in catalytic efficiency, however only a few showed significant decrease (Figure
11C). This suggests that active site-flanking lysine residues may play greater of a role in
the release of product and possibly the regeneration of enzyme than in substrate binding.
Mutating the lysine residue to glutamic acid, resulted in a charge change for the
residue from positive to negative. From the kinetic assays at both pH 7.4 and 6.5, it is
observed that the change in charge greatly affects the redox activity of PDI (Figure 8 and
Figure 11). The catalytic efficiency of the enzyme is greatly reduced by the presence of
the negative charge incurred by the glutamic acid (Figure 8C and Figure 11C). This
suggests a post-translation modification such as succinylation, which causes a change in
charge to lysine would have a greater effect on PDI redox activity (Zhang et al., 2011).
Further studies into succinylation of PDI should be conducted, due to the fact that this
much larger and negatively charged modification would affect PDI redox activity greatly.
Conclusions drawn from the acetylation of PDI by acetic anhydride should be
considered cautiously as previously stated. However, the kinetic assay possibly suggests
that acetylation of the active site-flanking lysine residue could adversely affect substrate
binding (Figure 18A). Although, acetylation at non-active site lysine residues may
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actually result in an improvement of product release from the enzyme (Figure 18C). Due
to the fact that there is a study demonstrating that acetylation occurs on PDI, additional
research is required to further understand the consequences of this post-translational
modification.
To further study the relationship of acetylation on PDI’s redox activity, one could
possibly obtain acetyltransferases present in the ER to perform acetylation. Such
acetyltransferases are ATase 1 and ATase 2, which belong to the GNAT superfamily
(Pehar & Puglielli, 2013). Performing acetylation in vitro would be the simplest method
to obtain improved valid results on the regulation of PDI by acetylation. To further study
the effects of lysine acetylation, in vivo experiment should be conducted to obtain the
most accurate lysine acetylation of PDI. In all these future experiments acetylated PDI
should be isolated from un-acetylated PDI using antibodies for acetylation. These
experiments would provide a more accurate account for how acetylation would regulate
PDI activity.
The experiments performed in this study, highly suggest that lysine plays a
critical role in PDI redox activity. The active site-flanking lysine residues play an
important role for optimal substrate binding as well as for optimal turnover rate for the
enzyme. The catalytic efficiency of wt-PDI discovered through our analysis was higher
than previously reported (Raturi & Mutus, 2007). This study hints that acetylation may
play a possible role in post-translational modification used by cells to regulate PDI
activity. Further studies are required to fully understand how exactly acetylation may
regulate PDI redox activity. However, in this report, it is suggested that acetylation may
have activation and inhibitory effects on PDI redox activity. More investigation should be
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performed on how different types of post-translational modifications regulate PDI
activity, specifically on lysine residues. Notable post-translational modifications to
investigate include methylation and succinylation.
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